Commercial Channels

As part of the agreement, Novo will be paid both development and commercial milestone payments for NN-8828, is currently in Phase II of non-dermatological indications.

The partnership revolves around meeting various agency standards and industry requirements pertaining to the drug development and manufacturing lifecycle.

Properly supporting market access for a newly launched product with a single indication is challenging. Doing so for multiple indications, or supporting subsequent indications, can have a compounding effect on the degree of difficulty for getting everything right.

Per the deal, the company establishes Regeneron Cell Medicines, while also providing it with access to the collection’s full development and commercialization rights.

LillyDirect will facilitate access to medications by connecting patients with independent telehealth providers, bypassing the need to obtain a prescription from a physician and then going to a pharmacy to fill it.

Popular works in the category explore 340B guidelines, ‘smart pharma’ capabilities, and commercialization trends.

Session discusses ways to integrate digital pharmacies and hubs.

Panel uncovers ways to handle the increasing complexities and risks surrounding commercialization.

Conference keynote offers an industry outlook, including new commercialization challenges.

A study explores how supply and demand impact the value of medication.

Webinar Date/Time: Thu, Dec 14, 2023 11:00 AM EST

Financial commitment further strengthens IntegriChain’s platform as a source for pharma manufacturers' commercialization and market access goals.

Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle.

How drugmakers can better harness real-world evidence to drive their clinical and commercial objectives, while also providing greater clarity for healthcare providers and improved access to therapy for the patients they serve.

The conference will focus on the full breadth of commercialization strategies and operations.

A look into ways to approach change management using three factors.

The company anticipates that the offering will help maximize life sciences brands’ commercial potential.

How the ‘fight-for-the-dollar’ is coming and likely will impact the bundled pricing of industry stakeholders.

Sy Pretorius, COO & president of outsourced solutions at Eversana, dives into his new role in the space, after being a veteran in the clinical development sector.

New PC column explores commercialization trends and how pharma can adjust to the new squeeze of market, regulatory, pricing, and gross-to-net pressures.

The latest IT offerings for sales force automation—including new AI tools—promise a more effective pharma sales process.

How pharma can harness digitalization all the way through commercialization

Document reveals that 20 of 28 of participating Big Pharma manufacturers saw their DIO increase by an average of 5%, suggesting that large amounts of inventory do not necessarily offer protection from running low on medication.

New federal law introduces significant changes in the design of pharmacy benefit plans with aims to level the playing field between PBMs and their employee healthcare benefit plan clients.

Acquisition is expected to drive organization’s ‘next phase of growth.’

Site expected to support growth of advanced analytics and data science team.

Acquisition of Evolution Road expands company’s omnichannel know-how

Stakeholders are investing heavily in their ability to curate appropriate data sets and devise advanced data-analytics capabilities to harness real-world evidence (RWE) across the entire pharma lifecycle—from drug discovery and development through product launch and commercialization

How to make commercial AI actionable in the last mile, helping to better realize data science investment and improve customer engagement

How biopharma commercial teams can leverage machine learning techniques to improve targeting of HCPs and patients